Vault-13

FORWARD PHARMA A/S

SPONSORD ADS NEW · CUSIP 34986J204

1 institutional holders +0 vs Q1 2023
525525 shares reported held*
$300.0kreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $85.5m (-149.7k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $571.42.

Trends to Q2 2023

Institutional holders

Managers reporting a position, each quarter

0510Q3 22: 8Q4 22: 2Q1 23: 1Q2 23: 11Q3 22Q4 22Q1 23Q2 23
Numbers
QuarterHolders
Q3 20228
Q4 20222
Q1 20231
Q2 20231

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
10010Q4 22: 0 bought or addedQ4 22: 6 cut or sold outQ4 22Q1 23: 0 bought or addedQ1 23: 1 cut or sold outQ1 23Q2 23: 0 bought or addedQ2 23: 1 cut or sold outQ2 23
Numbers
QuarterBought or addedCut or sold out
Q4 202206
Q1 202301
Q2 202301

Biggest buyers

None

Biggest sellers

MASON CAPITAL MANAGEMENT LLC Reduced -149,692-149.7k

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 MASON CAPITAL MANAGEMENT LLC 0.03% of their portfolio NEW YORK, NY 525525 $300.0k $300.0k 0.03% Reduced -149.7k -149,692